List of Tables
Table 1. Global Short Peptide Enteral Nutrition Agents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Short Peptide Enteral Nutrition Agents Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Short Peptide Enteral Nutrition Agents Market Competitive Situation by Manufacturers in 2024
Table 4. Global Short Peptide Enteral Nutrition Agents Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Short Peptide Enteral Nutrition Agents Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Short Peptide Enteral Nutrition Agents Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Short Peptide Enteral Nutrition Agents Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Short Peptide Enteral Nutrition Agents Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Short Peptide Enteral Nutrition Agents, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Short Peptide Enteral Nutrition Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Short Peptide Enteral Nutrition Agents, Product Type & Application
Table 12. Global Key Manufacturers of Short Peptide Enteral Nutrition Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Short Peptide Enteral Nutrition Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Peptide Enteral Nutrition Agents as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Short Peptide Enteral Nutrition Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Short Peptide Enteral Nutrition Agents Sales by Region (2020-2025) & (K Units)
Table 18. Global Short Peptide Enteral Nutrition Agents Sales Market Share by Region (2020-2025)
Table 19. Global Short Peptide Enteral Nutrition Agents Sales by Region (2026-2031) & (K Units)
Table 20. Global Short Peptide Enteral Nutrition Agents Sales Market Share by Region (2026-2031)
Table 21. Global Short Peptide Enteral Nutrition Agents Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Short Peptide Enteral Nutrition Agents Revenue Market Share by Region (2020-2025)
Table 23. Global Short Peptide Enteral Nutrition Agents Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Short Peptide Enteral Nutrition Agents Revenue Market Share by Region (2026-2031)
Table 25. North America Short Peptide Enteral Nutrition Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Short Peptide Enteral Nutrition Agents Sales by Country (2020-2025) & (K Units)
Table 27. North America Short Peptide Enteral Nutrition Agents Sales by Country (2026-2031) & (K Units)
Table 28. North America Short Peptide Enteral Nutrition Agents Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Short Peptide Enteral Nutrition Agents Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Short Peptide Enteral Nutrition Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Short Peptide Enteral Nutrition Agents Sales by Country (2020-2025) & (K Units)
Table 32. Europe Short Peptide Enteral Nutrition Agents Sales by Country (2026-2031) & (K Units)
Table 33. Europe Short Peptide Enteral Nutrition Agents Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Short Peptide Enteral Nutrition Agents Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Short Peptide Enteral Nutrition Agents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Short Peptide Enteral Nutrition Agents Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Short Peptide Enteral Nutrition Agents Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Short Peptide Enteral Nutrition Agents Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Short Peptide Enteral Nutrition Agents Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Short Peptide Enteral Nutrition Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Short Peptide Enteral Nutrition Agents Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Short Peptide Enteral Nutrition Agents Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Short Peptide Enteral Nutrition Agents Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Short Peptide Enteral Nutrition Agents Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Short Peptide Enteral Nutrition Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Short Peptide Enteral Nutrition Agents Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Short Peptide Enteral Nutrition Agents Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Short Peptide Enteral Nutrition Agents Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Short Peptide Enteral Nutrition Agents Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Short Peptide Enteral Nutrition Agents Sales (K Units) by Type (2020-2025)
Table 51. Global Short Peptide Enteral Nutrition Agents Sales (K Units) by Type (2026-2031)
Table 52. Global Short Peptide Enteral Nutrition Agents Sales Market Share by Type (2020-2025)
Table 53. Global Short Peptide Enteral Nutrition Agents Sales Market Share by Type (2026-2031)
Table 54. Global Short Peptide Enteral Nutrition Agents Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Short Peptide Enteral Nutrition Agents Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Short Peptide Enteral Nutrition Agents Revenue Market Share by Type (2020-2025)
Table 57. Global Short Peptide Enteral Nutrition Agents Revenue Market Share by Type (2026-2031)
Table 58. Global Short Peptide Enteral Nutrition Agents Price (US$/Unit) by Type (2020-2025)
Table 59. Global Short Peptide Enteral Nutrition Agents Price (US$/Unit) by Type (2026-2031)
Table 60. Global Short Peptide Enteral Nutrition Agents Sales (K Units) by Application (2020-2025)
Table 61. Global Short Peptide Enteral Nutrition Agents Sales (K Units) by Application (2026-2031)
Table 62. Global Short Peptide Enteral Nutrition Agents Sales Market Share by Application (2020-2025)
Table 63. Global Short Peptide Enteral Nutrition Agents Sales Market Share by Application (2026-2031)
Table 64. Global Short Peptide Enteral Nutrition Agents Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Short Peptide Enteral Nutrition Agents Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Short Peptide Enteral Nutrition Agents Revenue Market Share by Application (2020-2025)
Table 67. Global Short Peptide Enteral Nutrition Agents Revenue Market Share by Application (2026-2031)
Table 68. Global Short Peptide Enteral Nutrition Agents Price (US$/Unit) by Application (2020-2025)
Table 69. Global Short Peptide Enteral Nutrition Agents Price (US$/Unit) by Application (2026-2031)
Table 70. Hospira Inc Company Information
Table 71. Hospira Inc Description and Business Overview
Table 72. Hospira Inc Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Hospira Inc Short Peptide Enteral Nutrition Agents Product
Table 74. Hospira Inc Recent Developments/Updates
Table 75. Fresenius Kabi Company Information
Table 76. Fresenius Kabi Description and Business Overview
Table 77. Fresenius Kabi Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Fresenius Kabi Short Peptide Enteral Nutrition Agents Product
Table 79. Fresenius Kabi Recent Developments/Updates
Table 80. Danone Company Information
Table 81. Danone Description and Business Overview
Table 82. Danone Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Danone Short Peptide Enteral Nutrition Agents Product
Table 84. Danone Recent Developments/Updates
Table 85. Knowmedical Company Information
Table 86. Knowmedical Description and Business Overview
Table 87. Knowmedical Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Knowmedical Short Peptide Enteral Nutrition Agents Product
Table 89. Knowmedical Recent Developments/Updates
Table 90. Nestlé Company Information
Table 91. Nestlé Description and Business Overview
Table 92. Nestlé Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Nestlé Short Peptide Enteral Nutrition Agents Product
Table 94. Nestlé Recent Developments/Updates
Table 95. B. Braun Melsungen AG Company Information
Table 96. B. Braun Melsungen AG Description and Business Overview
Table 97. B. Braun Melsungen AG Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. B. Braun Melsungen AG Short Peptide Enteral Nutrition Agents Product
Table 99. B. Braun Melsungen AG Recent Developments/Updates
Table 100. Abbott Company Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Abbott Short Peptide Enteral Nutrition Agents Product
Table 104. Abbott Recent Developments/Updates
Table 105. Otsuka Pharmaceutical India Private Limited Company Information
Table 106. Otsuka Pharmaceutical India Private Limited Description and Business Overview
Table 107. Otsuka Pharmaceutical India Private Limited Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Otsuka Pharmaceutical India Private Limited Short Peptide Enteral Nutrition Agents Product
Table 109. Otsuka Pharmaceutical India Private Limited Recent Developments/Updates
Table 110. NUTRICHEM DIÄT + PHARMA GMBH Company Information
Table 111. NUTRICHEM DIÄT + PHARMA GMBH Description and Business Overview
Table 112. NUTRICHEM DIÄT + PHARMA GMBH Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. NUTRICHEM DIÄT + PHARMA GMBH Short Peptide Enteral Nutrition Agents Product
Table 114. NUTRICHEM DIÄT + PHARMA GMBH Recent Developments/Updates
Table 115. Delta Drugs Company Information
Table 116. Delta Drugs Description and Business Overview
Table 117. Delta Drugs Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Delta Drugs Short Peptide Enteral Nutrition Agents Product
Table 119. Delta Drugs Recent Developments/Updates
Table 120. Baxter Company Information
Table 121. Baxter Description and Business Overview
Table 122. Baxter Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Baxter Short Peptide Enteral Nutrition Agents Product
Table 124. Baxter Recent Developments/Updates
Table 125. Allergan Company Information
Table 126. Allergan Description and Business Overview
Table 127. Allergan Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Allergan Short Peptide Enteral Nutrition Agents Product
Table 129. Allergan Recent Developments/Updates
Table 130. Actavis Inc. Company Information
Table 131. Actavis Inc. Description and Business Overview
Table 132. Actavis Inc. Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Actavis Inc. Short Peptide Enteral Nutrition Agents Product
Table 134. Actavis Inc. Recent Developments/Updates
Table 135. Grifols, S.A. Company Information
Table 136. Grifols, S.A. Description and Business Overview
Table 137. Grifols, S.A. Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Grifols, S.A. Short Peptide Enteral Nutrition Agents Product
Table 139. Grifols, S.A. Recent Developments/Updates
Table 140. Vifor Pharma Company Information
Table 141. Vifor Pharma Description and Business Overview
Table 142. Vifor Pharma Short Peptide Enteral Nutrition Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Vifor Pharma Short Peptide Enteral Nutrition Agents Product
Table 144. Vifor Pharma Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Short Peptide Enteral Nutrition Agents Distributors List
Table 148. Short Peptide Enteral Nutrition Agents Customers List
Table 149. Short Peptide Enteral Nutrition Agents Market Trends
Table 150. Short Peptide Enteral Nutrition Agents Market Drivers
Table 151. Short Peptide Enteral Nutrition Agents Market Challenges
Table 152. Short Peptide Enteral Nutrition Agents Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Short Peptide Enteral Nutrition Agents
Figure 2. Global Short Peptide Enteral Nutrition Agents Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Short Peptide Enteral Nutrition Agents Market Share by Type: 2024 & 2031
Figure 4. Powdered Type Product Picture
Figure 5. Suspension Type Product Picture
Figure 6. Emulsion Type Product Picture
Figure 7. Others Product Picture
Figure 8. Global Short Peptide Enteral Nutrition Agents Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Short Peptide Enteral Nutrition Agents Market Share by Application: 2024 & 2031
Figure 10. Pathogenic Diseases
Figure 11. Nutritional Deficiency Diseases
Figure 12. Genetic Diseases
Figure 13. Psychological Diseases
Figure 14. Other
Figure 15. Global Short Peptide Enteral Nutrition Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Short Peptide Enteral Nutrition Agents Market Size (2020-2031) & (US$ Million)
Figure 17. Global Short Peptide Enteral Nutrition Agents Sales (2020-2031) & (K Units)
Figure 18. Global Short Peptide Enteral Nutrition Agents Average Price (US$/Unit) & (2020-2031)
Figure 19. Short Peptide Enteral Nutrition Agents Report Years Considered
Figure 20. Short Peptide Enteral Nutrition Agents Sales Share by Manufacturers in 2024
Figure 21. Global Short Peptide Enteral Nutrition Agents Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Short Peptide Enteral Nutrition Agents Players: Market Share by Revenue in Short Peptide Enteral Nutrition Agents in 2024
Figure 23. Short Peptide Enteral Nutrition Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Short Peptide Enteral Nutrition Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Short Peptide Enteral Nutrition Agents Sales Market Share by Country (2020-2031)
Figure 26. North America Short Peptide Enteral Nutrition Agents Revenue Market Share by Country (2020-2031)
Figure 27. United States Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Short Peptide Enteral Nutrition Agents Sales Market Share by Country (2020-2031)
Figure 30. Europe Short Peptide Enteral Nutrition Agents Revenue Market Share by Country (2020-2031)
Figure 31. Germany Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Short Peptide Enteral Nutrition Agents Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Short Peptide Enteral Nutrition Agents Revenue Market Share by Region (2020-2031)
Figure 38. China Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Short Peptide Enteral Nutrition Agents Sales Market Share by Country (2020-2031)
Figure 46. Latin America Short Peptide Enteral Nutrition Agents Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Short Peptide Enteral Nutrition Agents Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Short Peptide Enteral Nutrition Agents Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Short Peptide Enteral Nutrition Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Short Peptide Enteral Nutrition Agents by Type (2020-2031)
Figure 56. Global Revenue Market Share of Short Peptide Enteral Nutrition Agents by Type (2020-2031)
Figure 57. Global Short Peptide Enteral Nutrition Agents Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Short Peptide Enteral Nutrition Agents by Application (2020-2031)
Figure 59. Global Revenue Market Share of Short Peptide Enteral Nutrition Agents by Application (2020-2031)
Figure 60. Global Short Peptide Enteral Nutrition Agents Price (US$/Unit) by Application (2020-2031)
Figure 61. Short Peptide Enteral Nutrition Agents Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
